Growth Metrics

Disc Medicine (IRON) Depreciation and Depletion (2020 - 2021)

Disc Medicine (IRON) reported Depreciation and Depletion of $46000.0 for Q4 2021, down 47.13% year-over-year from $87000.0 in Q4 2020, and down 20.69% on a QoQ basis from $58000.0 in Q3 2021.

Disc Medicine (IRON) has 2 years of Depreciation and Depletion data on file, last reported at $46000.0 in Q4 2021.

  • Quarterly Depreciation and Depletion fell 47.13% year-over-year to $46000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $46000.0 (down 83.09% YoY) and the FY2024 annual result came in at $200000.0, up 100.0% from the prior year.
  • Depreciation and Depletion retreated to $46000.0 in Q4 2021 per IRON's latest filing, from $58000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $87000.0 in Q4 2020 and bottomed at $46000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1,395.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Disc Medicine 2.76 Bn 2.03 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 46,000.00
Dec 31, 2021 46,000.00
Sep 30, 2021 58,000.00
Sep 30, 2021 58,000.00
Jun 30, 2021 62,000.00
Jun 30, 2021 62,000.00
Mar 31, 2021 65,000.00
Mar 31, 2021 65,000.00
Dec 31, 2020 87,000.00
Dec 31, 2020 87,000.00
Sep 30, 2020 80,000.00
Sep 30, 2020 80,000.00
Jun 30, 2020 78,000.00
Jun 30, 2020 78,000.00
Mar 31, 2020 77,000.00
Mar 31, 2020 77,000.00